Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 701–800 of 931
Type I interferon signaling promotes kainic acid-induced seizures through mTOR activation
Ma, J.-H., Eo, J.-C., Lee, C., Choi, J.-H., Hwang, I., Yang, Y.-J., Shin, S. J., Kim, C. H., & Yu, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110634 · Cited by 5
Zhou, P., Peng, Y., Yang, G., Xie, D., Yan, J., Ma, J., Dong, W., & Chen, C.-P. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118429 · Cited by 2
The Development of UM-203, A Reversible Covalent STING Antagonist
Barasa, L., DeOrsey, L., O’Reilly, M. D., Choudhary, S., Cahill, S. E., Mathur, A., Allabaji, A., Vidadala, S. R., Sarkar, S. K., Patil, S. N., et al. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00611 · Cited by 2
Emreol, H. E., Ünal, D., Cağdaş, D. N., Bilginer, Y., & Özen, S. (2026) · Rheumatology · doi:10.1093/rheumatology/keaf695 · Cited by 2
IFN response regulation upon viral infections
Chiale, C. (2026) · Advances in genetics · doi:10.1016/bs.adgen.2025.11.007 · Cited by 2
Aicardi-Goutières Syndrome caused by SAMHD1 mutation: Pathogenesis and Beyond
Li, Y., & Ying, S. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110680 · Cited by 3
Inside Out: How Cellular Localisation Shapes cGAS Functions in Health and Disease
Wu, J., Zhou, Y., Zeng, B., Wang, Y., & Wang, C. (2026) · Immunology · doi:10.1111/imm.70133 · Cited by 2
Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
Saez‐Diez, E. G., Ferrer, M., Yang, K., Battaglia, N., Zaman, Z., Bennett, M. L., Vanderver, A. L., Lee, P. Y., Henderson, L. A., Andzelm, M. M., et al. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70407 · Cited by 2
An Overview of Genetics of Moyamoya: Beyond RNF213 Gene
Sorte, G., Cantone, M., Bella, R., Salemi, M., Zedde, M., & Zappia, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104431 · Cited by 2
“Pathophysiologically, these mutations lead to a near-total loss of SAMHD1 protein expression and are linked to a constitutive type I interferon (IFN) signature, a hallmark of Aicardi–Gouti è res syndrome [32].”
cGAS‐STING do it again: pivotal role in RNase H2 genetic disease
Gentili, M., & Manel, N. (2016) · The EMBO Journal · doi:10.15252/embj.201694226 · Cited by 4
“T he auto-inflammatory genetic disease termed Aicardi – Goutie`res syndrome (AGS) is characterized by an increased expression of interferon-stimulated genes (ISG) and is now considered an interferonopathy (Crow & Manel, 2015).”
Self-citationSAMHD1 agit sur les fourches de réplication bloquées pour empêcher l’induction d’interféron
Coquel, F., Silva, M. J., Técher, H., Zadorozhny, K., Sharma, S., Nieminuszczy, J., Mettling, C., Dardillac, E., Barthe, A., Schmitz, A.-L., et al. (2020) · Comptes Rendus Biologies · doi:10.5802/crbiol.10 · Cited by 2
“Le syndrome d’Aicardi-Goutières est une encéphalopathie provoquée par des mutations de différents enzymes du métabolisme des acides nucléiques et une production chronique d’interféron de type I [1].”
BackgroundFelley‐Bosco, E. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-4 · Cited by 2
“MDA5 G495R is representative of mutations in MDA5 leading to aberrant activation of its signaling activity, resulting in a spectrum of immune disorders, such as systemic lupus erythematosus, or Aicardi-Goutières syndrome (51).”
BackgroundRNA modification of an RNA modifier prevents self-RNA sensing
Snider, D. L., & Horner, S. M. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001342 · Cited by 2
“Indeed, the autoimmune disease Aicardi–Goutières syndromeAU : Anabbreviationlisthasbeencompiledforthoseusedinthemaintext:Pleaseverifythatallentriesarecorrect: (AGS) is associated with mutations in genes encoding dsRNA sensing or processing proteins, such as the dsRNA sensor MDA5 and the cellular RNA deaminase ADAR1 [3…”
BackgroundLi, X., Yuan, S.-C., Wang, M., Su, Z., Zhao, M., Li, T., Zhang, X., Xue, W., & Li, W. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.113 · Cited by 3
Wang, C. S. (2023) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2023.06.002 · Cited by 3
Recurrent Tumefactive Central Nervous System Lesions Due to BRIP1-Related Fanconi Anemia
Nathoo, N., Gavrilova, R. H., Trejo‐Lopez, J. A., McGarrah, P. W., Go, R. S., Alqallaf, A., & Tobin, W. O. (2023) · The Neurologist · doi:10.1097/nrl.0000000000000511 · Cited by 2
Yuan, X., Shi, J., Zhao, P., Peng, L., Zhou, S., Wu, C., Zhao, J., Xu, D., Li, M., Wang, Q., et al. (2024) · Clinical Rheumatology · doi:10.1007/s10067-023-06851-x · Cited by 2
“Furthermore, previous evidence has shown that MDA5 activity was also associated with the risk of various auto-immune diseases, such as systemic lupus erythematosus [5], Aicardi–Goutières syndrome [6], type 1 diabetes [7], and some forms of cancer [8].”
To cleave or not and how? The DNA exonucleases and endonucleases in immunity
Lu, M., Wu, J., Gao, Q., Jin, R., An, C., & Ma, T. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101219 · Cited by 4
“65 Among them, cyclic GMP-AMP synthase acts as a DNA receptor in the cytoplasm and binds to DNA to form the cGAS-DNA complex.”
Characterization of Fine Motor and Visual Motor Skills in Aicardi-Goutières Syndrome
Cusack, S. V., Gavazzi, F., de Barcelos, I. P., Modesti, N. B., Woidill, S., Formanowski, B. L., DeMauro, S. B., Lorch, S. A., Vincent, A., Jawad, A. F., et al. (2024) · Journal of Child Neurology · doi:10.1177/08830738241241786 · Cited by 4
Modeling the transmission dynamics of COVID-19 with genetically resistant humans
Onifade, A. A., Idisi, I. O., & Kareem, L. A. (2024) · Scientific African · doi:10.1016/j.sciaf.2024.e02240 · Cited by 2
Childhood-inherited white matter disorders with calcification
Livingston, J. H. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-99209-1.00013-2 · Cited by 2
Stillman, J. M., Kiniwa, T., & Schafer, D. P. (2024) · Immunological Reviews · doi:10.1111/imr.13420 · Cited by 2
Mouse models of type I interferonopathies
Luca, D., & Kato, H. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae187 · Cited by 2
“…and SAMHD1 are associated with Aicardi–Goutières syndrome (AGS), an established type I interferonopathy that consistently affects the brain, defined by features such as basal ganglia calcifications and white matter abnormalities [27], and the skin with symptoms such as chilblain-like lesions [28].”
Mouse models for understanding physiological functions of ADARs
Zhang, Q., & Walkley, C. R. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2024.11.024 · Cited by 2
Yamazaki, S., Kaneko, S., Shimbo, A., Irabu, H., Ogino, R., Miyamoto, T., Izawa, K., Segawa, Y., Kakizaki, J., Mori, M., et al. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2479148 · Cited by 3
“AGS, first described in 1984 by Jean Aicardi and Françoise Goutières, is an early-onset, progressive familial encephalopathy clinically characterized by intracranial calcification, white matter disease, and cerebrospinal fluid lymphocytosis, indicating an inflammatory process [11,12].”
Interferons in human inborn errors of disease
Stine, L., Cahill, S. E., & Humphries, F. (2025) · mBio · doi:10.1128/mbio.01570-25 · Cited by 2
“The AGS-associated ISG molecular signature in patient cells has become a key biomarker of AGS and an important early diagnostic tool (10, 14).”
Gázquez-Gutiérrez, A., Chin, P., Peris, G., Gordon, K., Marchante, P. G., Witteveldt, J., Tristán-Ramos, P., Rouvière, J. O., Knol, L. I., Ivens, A. C., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag190 · Cited by 3
“One of the primary responses to dsRNA is the production of type I IFNs, which can be harmful if inappropriately activated, as in the case of type I interferonopathies [ 80 ].”
Aicardi-Goutieres Syndrome-A Case Report
Liza, N. A. S., Anwar, S. S., & Kundu, G. K. (2022) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v40i2.58697 · Cited by 2
Exonuclease TREX1 also Has a Sweet Tooth
Barchet, W., & Zillinger, T. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.026 · Cited by 2
“Recent years have seen immense progress in unraveling nucleic acid receptors and their signaling pathways, and many of the gene variants associated with ISG-driven autoimmune syndromes have been identified (Crow and Manel, 2015).”
BackgroundFigiel, M., & Nowotny, M. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.03.009 · Cited by 3
Sugawara, Y., Imai, K., Kashimada, A., Moriyama, K., Baba, S., Nishikomori, R., Motegi, M., Takeuchi, Y., & Morio, T. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.019 · Cited by 2
Degenerative Disorders of the Newborn
Elitt, C. M., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00029-6 · Cited by 2
Lhamtsho, D., Rajesh, U., Saxena, A., Bhardwaj, G., & Sondhi, V. (2020) · BMJ Neurology Open · doi:10.1136/bmjno-2019-000018 · Cited by 2
Loosening the grip on nuclear cGAS
Humphries, F., & Fitzgerald, K. A. (2020) · Nature Genetics · doi:10.1038/s41588-020-00746-2 · Cited by 3
Liu, X., Lei, M., Xue, Y., Li, H., Yin, J., Li, D., Shu, J., & Cai, C. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10488-5 · Cited by 2
“As an inflammatory-associated early onset progressive encephalopathy (Crow and Manel 2015), Aicardi–Goutières syndrome (AGS) was first reported in 1984 (Aicardi and Goutieres 1984).”
Hamilton, N., Rutherford, H. A., Isles, H. M., Petts, J. J., Weber, T., Henneke, M., Gärtner, J., Dunning, M., & Renshaw, S. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/744144 · Cited by 2
“The phenotype of one of the more prevalent leukodystrophies—Aicardi Goutières Syndrome (AGS)—mimics congenital cytomegalovirus brain infection and is classified as an interferonopathy to account for the upregulation of type I IFN-induced signal apparently central to pathology (Crow and Manel, 2015).”
BackgroundThe majority of A-to-I RNA editing is not required for mammalian homeostasis.
Heraud-Farlow, J. E. (2020) · doi:10.26226/morressier.5ebd45acffea6f735881aee3 · Cited by 2
Liang, Z., Taylor, S., Goradia, A., Heraud-Farlow, J. E., & Walkley, C. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.24.497437 · Cited by 2
Miscellaneous Disorders of the Lysosome
Cox, T. M., & WINCHESTER, B. G. (2022) · doi:10.1002/9781119697312.ch23 · Cited by 2
IFNγ initiates TLR9-dependent autoimmune hepatitis in DNase II deficient micePreprint
Hao, K., Gao, K. M., Strauss, M. J., Subramanian, S., & Marshak‐Rothstein, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602775 · Cited by 3
MDA5 guards against infection by surveying cellular RNA homeostasisPreprint
Sampaio, N. G., Gearing, L. J., Dias, A. G., Chauveau, L., Odon, V., Cursi, C., Mayer, A., Ratnadiwakara, M., Änkö, M., Hertzog, P. J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6466919/v1 · Cited by 2
Sakhuja, K., Hartono, S. R., Sanz, L. A., Ijiri, E., Darling, C. L., Dye, L., Iben, J., Chon, H., Cerritelli, S. M., Crouch, R. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.30.651504 · Cited by 1
Interferons and cytokines in SLE pathogenesis and therapy
Koumpouras, F., & Bucala, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820583-9.00015-4 · Cited by 1
Role of epigenetics and alterations in RNA metabolism in leukodystrophies
Rey, F., Esposito, L., Maghraby, E., Mauri, A., Berardo, C., Bonaventura, E., Tonduti, D., Carelli, S., & Cereda, C. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1854 · Cited by 4
“It is also classified as interferonopathy (Liu & Ying, 2023; Pulliero et al., 2011) and is a severe childhood autoinflammatory disease that has a genetic basis and severe clinical features (Crow & Manel, 2015).”
BackgroundOrally bioavailable STING antagonist synthesized via multi-component Povarov–Doebner type reaction
Owusu, K. B., Samal, J., Hernandez, D. E., & Sintim, H. O. (2024) · Chemical Communications · doi:10.1039/d4cc03228d · Cited by 1
Ouhenach, M., Nada, A., Lyahyai, J., & Sefiani, A. (2025) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63997 · Cited by 1
“This indicates the early inflammatory stage of encephalopathy (Goutières and Aicardi 1982; Vanderver et al. 2015; Crow and Manel 2015).”
ATAD3 duplications bridge mitochondrial diseases and Aicardi–Goutières syndrome
Planté‐Bordeneuve, P., Bérat, C., Hanein, S., Gitiaux, C., ATAD3 Study Group, Steffann, J., Desguerre, I., Rötig, A., Boddaert, N., & Barcia, G. (2025) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.16414 · Cited by 2
Varesio, C., Politano, D., Adang, L. A., Ballante, E., Battini, R., Bertini, E., Borgatti, R., GIORGIS, V. D., Boca, A., Dragoni, F., et al. (2025) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2025.07.011 · Cited by 1
Kollia, M. E., Mouskou, S., Mentesidou, L., Syggelou, A., Anagnostopoulou, K. K., & Maritsi, D. (2025) · Cureus · doi:10.7759/cureus.91485 · Cited by 1
Petrov, A. Y., Tataurshchikova, N. S., Коваленко, А. Л., & Максимова, А. В. (2025) · Journal of Adaptive Medical Immunology and Public Health Issues · doi:10.17116/immunology2025101139 · Cited by 1
Discovery of the thieno[2,3-b][1,4]thiazin-2(3H)-one STING inhibitors
Han, L., Zang, S., Li, W., Yue, H., Zhou, X., Chen, J., Geng, M., Duan, W., Xie, Z., & Zhan, Z. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118571 · Cited by 1
Depletion of the RNA‐Editing Enzyme ADAR1 Invigorates the Antitumor Immunity of NK Cells
Chen, S., Lu, D., Liang, R., Tan, W., Zhao, E., Wu, S., Li, X., Song, Y., Wan, M., Xie, X., et al. (2026) · Advanced Science · doi:10.1002/advs.202517216 · Cited by 2
Batignes, M., Luka, M., Jagtap, S., de Cevins, C., Nemazanyy, I., Leib, J., Fali, T., Pierga, A., Zarhrate, M., García-Paredes, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69979-9 · Cited by 4
“Extra-neurologicalinvolvement can also occur,including vasculitischilblain-like lesions, and features consistent with systemic lupus erythematosus (SLE) in some cases 9 .”
Protective and pathogenic: The Janus-faced role of cGAS–STING in the brain
Corona, C., Kanzlemar, C., Hussaini, S. A., & Ratan, R. R. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261427904 · Cited by 2
“48 The beneficial versus detrimental nature of interferon signaling thus hinges, in part, on its temporal context.”
DNA polymerase μ protects macrophages from DNA damage produced during pro-inflammatory activation
Batlle-Recoder, C., Estrella, L. V., Ferri, M., Serra, M. M., Bernad, A., Sebastián, C., Lloberas, J., & Celada, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117081 · Cited by 1
Yoo, H., Nakahama, T., Sugihara, R., Gao, Y., Ishizawa, Y., Yang, J., Ni, Z., Iwasaki, M., Kato, Y., & Kawahara, Y. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117113 · Cited by 3
Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS
Guo, Z.-L., Sun, L.-M., Jiang, S., Zhao, M., Li, Y., Qian, J., Fu, Y., Wu, C., Yuan, Y., Xue, W., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70794-5 · Cited by 2
“The de fi ciency of TREX1 has been identi fi ed in patients with SLE 23 and Aicardi-Goutières syndrome (AGS) 24 – 26 , and the Trex1 – / – mice exhibit similar symptoms seen in human AGS patients 26 .”
The roles of cGAS-STING pathway in cancer
Sun, J., Wang, R. L., Wang, J., & zhang, L. (2026) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000136 · Cited by 4
A unique Z-shaped tetramer mediates the autoinhibition of waterfowl STING
Zhao, Z., Huang, X., Wu, L., & Li, X. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014111 · Cited by 1
Wege, L., Klemann, C., Siegert, S., Bley, A. E., Koss, S., Koy, A., Langer, T., Dunst, F., Plecko, B., Fleger, M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1782352 · Cited by 1
The Development of UM-232, a Covalent STING Antagonist
Barasa, L., DeOrsey, L., O’Reilly, M. D., Cahill, S. E., Choudhary, S., Allabaji, A., Vidadala, S. R., Sarkar, S. K., Patil, S. N., Hale, J., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00114 · Cited by 1
Zhao, T., Chen, D., Chen, Z., Wang, Q., Qing, J., Huang, Q., Zhao, Y., & Zhu, L. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11634-y · Cited by 1
“Loss-of-function mutations in the nuclease Trex1 result in the accumulation of cytoplasmic self-DNA, continuously activating the cGAS-STING pathway and triggering severe inflammatory responses in Aicardi-Goutières syndrome and systemic lupus erythematosus [2].”
Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders
Alsaati, N., & Satter, L. F. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.05.019 · Cited by 1
Zhuang, J.-H., Zhang, Q.-H., Zhou, S., Wen, Y., Li, Y., Peng, S., Yu, S., Liu, Z., Lin, G.-Q., Zhang, C., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119146 · Cited by 1
Loss of cellular RNA homeostasis contributes to MDA5 activation during virus infection
Sampaio, N. G., Davis, T., Gearing, L. J., Dias, A. G., Chauveau, L., Wray‐McCann, G., Odon, V., Liudkovska, V., McAllan, A. L., Cursi, C., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02614-3 · Cited by 7
“Excessive or uncontrolled T1-IFN responses fail to protect against infection and lead to long-term damage and disease 4,5 .”
Recurrent chilblains in a child with neurological impairment
Mohandas, P., Bowker, R., Ravenscroft, J., & Bleiker, T. O. (2017) · Clinical and Experimental Dermatology · doi:10.1111/ced.13330 · Cited by 1
Crossley, M. P., & Cimprich, K. A. (2018) · Nature · doi:10.1038/d41586-018-02804-6 · Cited by 1
The spatial organization of cGAS-TREX1 interactions
Juricic, P., & Ablasser, A. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.03.016 · Cited by 1
Le interferonopatie di tipo I: Una nuova classe di malattie autoinfiammatorie
Tommasini, A., Bruno, I., Morelli, M. E., & Lepore, L. (2021) · Medico e Bambino · doi:10.53126/meb40509 · Cited by 1
Bai, W., Wang, R., Shen, M., Li, M., & Zeng, X. (2022) · Rheumatology and Immunology Research · doi:10.2478/rir-2022-0008 · Cited by 1
“[1] Since IFN-I, including IFN-α and IFN-β, affects not only innate immunity, but also adaptive immunity,[2] type I interferonopathy may be characterized by autoinflammation manifestations such as fever, cutaneous rash, or intracranial calcifications, and varying autoimmune features such as positive autoantibodies, sy…”
BackgroundTsuchiya, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-76496-2_2 · Cited by 1
Wiley, C. A., & Wang, Q. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335808 · Cited by 1
“Mutations in seven genes associated with nucleic acid metabolism have been linked to AGS (Crow and Manel, 2015; Rice et al., 2017).”
BackgroundJamee, M., & Rezaei, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824466-1.00007-8 · Cited by 1
Unconventional functions of miRNAs
Bosisio, D., Gaudenzi, C., Sozzani, S., & Salvi, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00011-x · Cited by 2
Leung, M. L., Woodhull, W., Uggenti, C., Schord, S., Mato, R. P., Rodriguez, D., Ream, M. A., Crow, Y. J., & Mori, M. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104731 · Cited by 1
Self-citationDevelopment of an RNase H2 Activity Assay for Clinical Screening
Schulz, M. S., von Bach, C. B. S., Marinković, E., Günther, C., Behrendt, R., & Roers, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041598 · Cited by 1
Rioux, B., Chong, M., Walker, R. M., McGlasson, S. L., Rannikmäe, K., McCartney, D. L., McCabe, J. J., Brown, R. B., Crow, Y. J., Hunt, D. P. J., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.20385.1 · Cited by 1
“…described, most frequently present in early childhood with progressive encephalopathy, skin vasculopathy, and autoimmunity 8 , in addition to prominent white matter hyperintensities, calcifications and large vessel disease (aneurysms, arterial calcifications, stenoses) on brain imaging 9 .”
BackgroundMethodSelf-citationDocking simulations of small molecule drugs based on the innate immune cGAS-STING signaling pathway
Lin, Y. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3013001 · Cited by 1
Structural impacts of two disease-linked ADAR1 mutants: a molecular dynamics study
Huang, W., Hsu, C.-H., Albu, T. V., & Yang, C. (2024) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-024-00565-1 · Cited by 1
Successful Electroconvulsive Therapy in Aicardi-Goutières Syndrome Presenting Psychiatric Symptoms
Gil, M., Caballero-González, M., & Rios, N. A. (2024) · Journal of Ect · doi:10.1097/yct.0000000000001067 · Cited by 1
Exploring the anti-inflammatory potential of phytochemicals against STING::TBK1 pathway
Sood, A., & Kulharia, M. (2024) · Molecular Simulation · doi:10.1080/08927022.2024.2400326 · Cited by 1
“Autoimmune diseases like Aicardi-Goutieres syndrome [33], systemic lupus erythematosus (SLE) [34], may result from the activation of the STING pathway by self-DNA or DNA that has been mislocalised within the cell [35].”
The role of cytokines and interferons during pregnancy
Belokrinitskaya, T. E., Vitkovsky, Y. A., & Frolova, N. I. (2024) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2024-9-3-98-108 · Cited by 2
Degenerative Disorders of the Newborn
Elitt, C. M., & Volpe, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10513-5.00033-4 · Cited by 1
Hanai, S., Kobayashi, Y., Iwamoto, T., & Nakagomi, D. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2543612 · Cited by 1
“Type I interferonopathies are monogenic diseases that show constitutive production and dysregulation of type I IFN, and patients with these diseases can present with panniculitis [9].”
Type I Interferonopathies: From Pathophysiology to Clinical Expression
Flessa, C., Argiriou, E., & Mavragani, C. P. (2019) · Springer eBooks · doi:10.1007/978-3-319-96929-9_10 · Cited by 2
Cell Death and Autoimmune Disease
Gallucci, S., Caricchio, R., & Cohen, P. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00016-6 · Cited by 2
Özen, S. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.130 · Cited by 1
Casazza, R. L., Philip, D. T., & Lazear, H. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.04.475019 · Cited by 1
Popova, G., Retallack, H., Kim, C. N., Wang, A., Shin, D., DeRisi, J. L., & Nowakowski, T. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513565 · Cited by 1
Enhanced Inflammatory Signaling Driven by Metabolic Switch in Aicardi-Goutières SyndromePreprint
Batignes, M., Luka, M., Jagtap, S., de Cevins, C., Nemazanyy, I., Fali, T., García-Paredes, V., Carbone, F., Pérot, B. P., Neven, B., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.02.23.529707 · Cited by 1
Self-citationQuack, S., Maity, S., America, P. P. B., Klein, M., del Valle, A. H., Singh, R., Smitskamp, Q., Papini, F. S., Broedersz, C. P., Roos, W. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.27.609867 · Cited by 1
Zhu, Y., Li, A., Maji, S., Lee, B. J., Korn, S. M., Gertie, J. A., Dorrity, T. J., Wang, J., Wang, K. J., Pelletier, A., et al. (2025) · bioRxiv · doi:10.1101/2025.01.31.633084
A scalable proteogenomic framework for dissecting phospho-signaling pathways in primary immune cellsPreprint
Beusch, C. M., Morningstar, C., Semaan, M., Monaco, C. M., Welbourn, S., Swaldi, H., Ko, J., Kenney, D., Sousa, A. A., Sakai, H. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.681012 · Cited by 1
“CD4 T cells are not only central regulators of adaptive immunity but are also implicated in interferon-driven pathology across diverse inflammatory and autoimmune conditions 19 .”
Espinosa, J. M., Galbraith, M. D., Rachubinski, A. L., & Sullivan, K. D. (2022) · INCLUDE Data Hub · doi:10.71738/p0a9-2v09 · Cited by 1
The Toll of too much Interferon
Maria, N. I. (2015) · EUR Research Repository (Erasmus University Rotterdam)
Regulation of Stress Response and Innate Immunity by dsRNA-binding proteins PACT and TRBP
Vaughn, L. S. (2015) · Scholar Commons (University of South Carolina)
Bélot, A., & Picard, C. (2016) · médecine/sciences · doi:10.1051/medsci/20163205004
Quoi de neuf en dermatologie pédiatrique ?
Maruani, A. (2015) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(16)30004-7
Fontanella, A., Nardi, R., Masina, M., & Uomo, G. (2017) · Italian Journal of Medicine · doi:10.4081/itjm.q.2017.7
Taye, B. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72814
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.